Genscript Biotech (HK:1548) has released an update.
Genscript Biotech Corporation has announced the grant of restricted shares to selected grantees under its 2019 and 2021 restricted share award schemes. The grants, which include over 1.2 million restricted shares, are set to vest in multiple batches from 2025 to 2029, with specific performance targets for some grantees. This strategic move aims to incentivize and retain key personnel by aligning their interests with the company’s long-term growth and shareholder value.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
